Terumo Corporation logo

Terumo Corporation (4543)

Market Open
10 Aug, 06:00
JPX JPX
¥
2,575. 50
+202.5
+8.5335%
¥
3.93T Market Cap
39.65 P/E Ratio
52% Div Yield
8.4M Volume
0 Eps
¥ 2,373
Previous Close
Add Transaction
Day Range
2,455.5 2,579.5
Year Range
1,900 2,818
Want to track 4543 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

4543 trading today higher at ¥2,575.5, an increase of 8.5335% from yesterday's close, completing a monthly increase of 17.6296% or ¥386. Over the past 12 months, 4543 stock gained 12.7874%.
4543 pays dividends to its shareholders, with the most recent payment made on Dec 01, 2025. The next announced payment will be in In 1 month on Sep 29, 2026 for a total of ¥18.
The last earnings report, released on May 19, 2026, missed the consensus estimates by -13.69%. On average, the company has fell short of earnings expectations by -4.5633%, based on the last three reports.
Terumo Corporation has completed 3 stock splits, with the recent split occurring on Mar 28, 2024.
The company's stock is traded on 9 different exchanges and in various currencies, with the primary listing on JPX (JPY).

4543 Chart

People also search for

Sony Group Corp.
¥ 3,764
+1.1556%
Nintendo Co., Ltd.
¥ 8,265
+2.7602%
Keyence Corporation
¥ 85,000
-0.1292%
HOYA Corporation
¥ 26,250
+2.3791%
Fujitsu Limited
¥ 3,719
+1.1973%

Terumo Corporation (4543) FAQ

What is the stock price today?

The current price is ¥2,575.50.

On which exchange is it traded?

Terumo Corporation is listed on JPX.

What is its stock symbol?

The ticker symbol is 4543.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 52%.

What is its market cap?

As of today, the market cap is 3.93T.

Has Terumo Corporation ever had a stock split?

Terumo Corporation had 3 splits and the recent split was on Mar 28, 2024.

Terumo Corporation Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Hikaru Samejima CEO
JPX Exchange
JP3546800008 ISIN
JP Country
30,207 Employees
29 Sep 2026 Last Dividend
28 Mar 2024 Last Split
- IPO Date

Overview

Terumo Corporation, headquartered in Tokyo, Japan, is a globally recognized company in the medical product and equipment manufacturing sector. Its operations span across various continents including Japan, Europe, China, the United States, and other parts of Asia. The company's history dates back to 1921, initially founded as Sekisen Ken-onki Corporation before adopting its current name in October 1974. Terumo's business activities are organized into three main segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company, each focusing on distinct medical technologies and solutions aimed at improving patient care and medical outcomes.

Products and Services

  • Cardiac and Vascular Company:

    Offers a wide range of products for cardiology and endovascular therapies, including angiographic guidewires, catheters, introducer sheaths, vascular closure devices, and stents. Their portfolio extends to devices for treating cerebral aneurysm (coils, stents, and intrasaccular devices), embolization systems, aspiration catheters, and clot retrievers for ischemic stroke. They also produce oxygenators, cardio-pulmonary bypass systems, and artificial vascular and stent grafts.

  • Medical Care Solutions Company:

    Provides products aimed at general medical care such as syringes, infusion and syringe pumps, infusion lines, and IV solutions. Their offerings include peritoneal dialysis fluids, pain management, and nutritious food products. Additionally, they provide blood glucose monitoring systems, disposable needles for pen injectors, insulin patch pumps, blood pressure monitors, and digital thermometers. Terumo also engages in contract manufacturing of prefilled syringes and needles for pharmaceutical packaging.

  • Blood and Cell Technologies Company:

    Specializes in products for blood management and cellular technologies, including blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, and centrifugal apheresis systems. They also offer solutions for cell expansion, supporting advanced therapies and research in the life sciences sector.

Contact Information

Address: 2-44-1, Hatagaya
Phone: 81 3 3374 8111